八十岁以上患者的前庭神经鞘瘤立体定向放射外科治疗:病例系列
回顾性分析35年间接受单次立体定向放射外科治疗的62例80岁及以上症状性前庭神经鞘瘤患者,中位年龄82岁,男性占61.3%。5年肿瘤控制率为95.6%,不良放射效应风险为4.8%,多数患者获得肿瘤与症状控制。
要点
- 80岁以上症状性前庭神经鞘瘤患者单次立体定向放射外科治疗后5年肿瘤控制率为95.6%。
- 不良放射效应风险为4.8%,3例出现不良放射效应,其中1例永久性面肌无力。
- 肿瘤控制与患者年龄、肿瘤体积、Koos分级、性别、放射外科边缘剂量或既往手术无关。
核心结论
- 立体定向放射外科治疗使大多数80岁以上前庭神经鞘瘤患者获得肿瘤和症状控制。
研究设计与样本
- 回顾性研究,纳入35年间接受单次立体定向放射外科治疗的62例80岁及以上症状性前庭神经鞘瘤患者。
- 患者中位年龄为82岁,男性占61.3%。
- 5例患者中立体定向放射外科作为计划性辅助治疗或用于既往部分切除后延迟进展。
主要发现
- 立体定向放射外科治疗后5年肿瘤控制率为95.6%,不良放射效应风险为4.8%。
- 肿瘤控制与患者年龄、肿瘤体积、Koos分级、性别、放射外科边缘剂量或既往手术管理无关。
- 4例患者接受额外管理:1例症状性进展需手术切除,2例症状性脑积水需脑脊液分流,1例肿瘤相关囊肿需延迟囊肿抽吸。
- 3例发生不良放射效应:1例永久性面肌无力(House-Brackmann II级),1例三叉神经病,1例步态障碍加重。
- 6例在立体定向放射外科前有可用听力,其中2例在4年后保持可用听力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The management of octogenarians with vestibular schwannomas (VS) has received little attention. However, with the increase in octogenarian population, more effort is needed to clarify the value of stereotactic radiosurgery (SRS) in this population. The aim of this study was to evaluate the safety and efficacy of SRS in this patient age group. METHODS: A retrospective study of 62 patients aged 80 years or older who underwent single-session SRS for symptomatic VS during a 35-year interval was performed. The median patient age was 82 years, and 61.3% were male. SRS was performed as planned adjuvant management or for delayed progression after prior partial resection in 5 patients. RESULTS: SRS resulted in a 5-year tumor control rate of 95.6% with a 4.8% risk of adverse radiation effects (ARE). Tumor control was unrelated to patient age, tumor volume, Koos grade, sex, SRS margin dose, or prior surgical management. Four patients underwent additional management including 1 patient with symptomatic progression requiring surgical resection, 2 patients with symptomatic hydrocephalus requiring cerebrospinal fluid diversion, and 1 patient whose tumor-related cyst required delayed cyst aspiration. Three patients developed ARE, including 1 patient with permanent facial weakness (House-Brackmann grade II), 1 who developed trigeminal neuropathy, and 1 who had worsening gait disorder. Six patients had serviceable hearing preservation before SRS, and 2 maintained serviceable hearing preservation after 4 years. A total of 44 (71%) patients died at an interval ranging from 6 to 244 months after SRS. CONCLUSION: SRS resulted in tumor and symptom control in most octogenarian patients with VS.
引用
- Head JR, Bin-Alamer O, Wei Z, et al. Vestibular Schwannoma Stereotactic Radiosurgery in Octogenarians: Case Series. Neurosurgery. 2023. PMID: 37294094. doi:10.1227/neu.0000000000002552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。